Clinical Trial: To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647744) titled 'To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer' on June 02.

Brief Summary: This is a single-arm, open-label, dose-escalating Phase 1 clinical study. It aims to evaluate the safety, tolerability and pharmacokinetic(PK) profiles of the investigational agent, and preliminarily assess its efficacy in subjects with advanced/metastatic renal cell carcinoma, and determine the recommended dose and infusion regimen for Phase 2 trials.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Renal Cell Carcinoma (RCC)

Intervention: DRUG: Anti-Human ...